mobile
news-insights-top

News & Insight

At Palisade Capital Management, we think differently than other asset managers. We believe in sharing ideas and research across teams—and now with you. Here you can gain access to our vast intellectual capital and decidedly different perspective, while seeing what we’ve been up to lately.



Tuesday, April 14, 2015
Rising Rates and the Strong Dollar:      The Case for Small Cap Investing
Posted in White Papers
In April 2015, Chief Investment Officer Dennison "Dan" T. Veru released a white paper discussing the allocation of capital in a rising interest rate and strong dollar environment.

Download the White Paper

For further information regarding this white paper or about Palisade Capital Management, please contact us at info@palcap.com.
Wednesday, April 01, 2015
PCEP II Portfolio Company Brickell Biotech, Inc. Signs Exclusive License and Development Agreement for BBI-4000 with Kaken Pharmaceutical Co., Ltd.
Posted in Private Equity News
Brickell Biotech, Inc. (“Brickell”), a clinical-stage pharmaceutical company focused on the development of differentiated, innovative therapeutics to satisfy current unmet medical needs in the global dermatology markets, today announced the signing of an exclusive license and development agreement for BBI-4000 with Kaken Pharmaceutical Co., Ltd. (“Kaken”), a top-tier specialty pharmaceutical company in Japan with strong experience in developing and commercializing novel dermatological drugs.
Tuesday, February 03, 2015
PCEPII Portfolio Company Brickell Biotech Announces $10M Series C Financing, Initiates Phase 2b Study of BBI-4000 in Patients with Axillary Hyperhidrosis, and Acquires Novel, Clinical-Stage Compound for the Oral Treatment of Atopic Dermatitis
Posted in Private Equity News
Brickell Biotech, Inc. (“Brickell”), a clinical-stage pharmaceutical company focused on the development of differentiated, innovative therapeutics to satisfy current unmet medical needs in the global dermatology markets, today announced a $10 million Series C financing round (the “Offering”). Brickell’s pipeline includes new molecular entities in dermatology for hyperhidrosis, atopic dermatitis, and acne.
Wednesday, November 19, 2014
PPPII Portfolio Company QualityHealth Acquired by Sharecare
Posted in Private Equity News
Sharecare, a comprehensive health and wellness engagement platform, today announced the acquisition of QualityHealth, a platform for identifying patients at large scale, and activating them to take relevant health-specific actions. As one of the industry’s largest permission-based databases, QualityHealth has more than 50 million registered members and touches 100 million health consumers each month across 175 different health, wellness and therapeutic categories. PPPII will continue to own Sharecare equity post-closing.
Tuesday, September 30, 2014
PCEPII Portfolio Company Shoe Sensation Growing Headquarters and Distribution Center in Clark County
Posted in Private Equity News
Shoe Sensation, Inc., a regional chain of family shoe stores, announced plans today to expand its corporate headquarters and distribution center in Clark County, creating up to 32 new jobs by 2017.
Monday, September 29, 2014
PCEPII Portfolio Company Mitralign Confirms First-In-Man Percutaneous Tricuspid Repair: Non-surgical option for tricuspid regurgitation could benefit 1.6 million U.S. patients
Posted in Private Equity News
Mitralign Inc., a cardiovascular device company, today reported on the successful use of its technology to perform a percutaneous repair on a patient with tricuspid regurgitation (TR).
‹ First  < 25 26 27 28 29 >  Last ›
Latest Research and White Papers
Monday, November 21, 2022
Short Duration Convertible Bonds: A Compelling Alternative to Traditional Fixed Income
The U.S. Federal Reserve’s fight against inflation through increases in the Fed Funds rate and quantitative tightening has led to the worst year on record for the U.S. fixed income markets (as measured by Bloomberg U.S. Aggregate Bond Index performance of -15.7% year-to-date through October 31, 2022). This environment, when combined with the potential for additional rate hikes, has resulted in significant losses to fixed income portfolios.
Find Out More and Request This White Paper

See all Research and White Papers



Select A Category

Connect with Us

One Bridge Plaza, Suite 1095, Fort Lee, New Jersey 07024 | (201) 585-7733 | Get Directions | Contact Us

Stay Informed

Sign up for our mailing list and stay up to date on the latest information and news from Palisade Capital Management.